Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00274781
Status:
COMPLETED
Last Update Posted:
2015-07-10
First Post:
2006-01-10
Brief Title:
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
Sponsor:
The Cleveland Clinic
Organization:
The Cleveland Clinic
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| de novo myelodysplastic syndromes | View |
| refractory anemia with excess blasts in transformation | View |
| refractory anemia with excess blasts | View |
| chronic myelomonocytic leukemia | View |
| secondary acute myeloid leukemia | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |